Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Removing transurethral catheter on postoperative day 2 after robot-assisted laparoscopic radical prostatectomy: towards a new standard?
Brassetti A, Emiliozzi P, Cardi A, DE Vico A, Iannello A, Scapellato A, Riga T, Pansadoro A, D'Elia G. Brassetti A, et al. Among authors: de vico a. Minerva Urol Nefrol. 2018 Feb;70(1):102-103. doi: 10.23736/S0393-2249.17.02917-4. Epub 2017 Jun 23. Minerva Urol Nefrol. 2018. PMID: 28651426 Free article. No abstract available.
Removing the urinary catheter on post-operative day 2 after robot-assisted laparoscopic radical prostatectomy: a feasibility study from a single high-volume referral centre.
Brassetti A, Proietti F, Cardi A, De Vico A, Iannello A, Pansadoro A, Scapellato A, Riga T, Emiliozzi P, D'Elia G. Brassetti A, et al. Among authors: de vico a. J Robot Surg. 2018 Sep;12(3):467-473. doi: 10.1007/s11701-017-0765-2. Epub 2017 Nov 25. J Robot Surg. 2018. PMID: 29177945
Is preoperative laparoscopy useful for impalpable testis?
Ferro F, Spagnoli A, Zaccara A, De Vico A, La Sala E. Ferro F, et al. Among authors: de vico a. J Urol. 1999 Sep;162(3 Pt 2):995-6; discussion 997. doi: 10.1016/S0022-5347(01)68044-3. J Urol. 1999. PMID: 10458419 Clinical Trial.
A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV.
Sajadi MM, Abbasi A, Tehrani ZR, Siska C, Clark R, Chi W, Seaman MS, Mielke D, Wagh K, Liu Q, Jumpa T, Ketchem RR, Nguyen DN, Tolbert WD, Pierce BG, Atkinson B, Deming D, Sprague M, Asakawa A, Ferrer D, Dunn Y, Calvillo S, Yin R, Guest JD, Korber B, Mayer BT, Sato AH, Ouyang X, Foulke S, Habibzadeh P, Karimi M, Aslanabadi A, Hojabri M, Saadat S, Zareidoodeji R, Kędzior M, Pozharski E, Heredia A, Montefiori D, Ferrari G, Pazgier M, Lewis GK, Jardine JG, Lusso P, DeVico A. Sajadi MM, et al. bioRxiv [Preprint]. 2024 Oct 17:2024.10.14.618178. doi: 10.1101/2024.10.14.618178. bioRxiv. 2024. PMID: 39464103 Free PMC article. Preprint.
136 results